Actuant Corp. (ATU) Has Surged To A 6-Month High On Q3 Results
Markets2018-06-20
0 Views
Actuant Corp. (ATU) reported third quarter adjusted EPS of $0.39 Wednesday morning, which topped the consensus estimate of $0.36.
Source: RTTNews
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
FDA Approves Aurinia Pharmaceuticals' (Nasdaq: AUPH / TSX: AUP) LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis
